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Abstract
Background. Body dysmorphic disorder (BDD) usually begins during adolescence but little is
known about the prevalence, etiology, and patterns of comorbidity in this age group. We
investigated the prevalence of BDD symptoms in adolescents and young adults. We also
report on the relative importance of genetic and environmental influences on BDD symptoms,
and the risk for co-existing psychopathology.
Methods. Prevalence of BDD symptoms was determined by a validated cut-off on the
Dysmorphic Concerns Questionnaire (DCQ) in three population-based twin cohorts at
ages 15 (n = 6968), 18 (n = 3738), and 20–28 (n = 4671). Heritability analysis was performed
using univariate model-fitting for the DCQ. The risk for co-existing psychopathology was
expressed as odds ratios (OR).
Results. The prevalence of clinically significant BDD symptoms was estimated to be between 1
and 2% in the different cohorts, with a significantly higher prevalence in females (1.3–3.3%)
than in males (0.2–0.6%). The heritability of body dysmorphic concerns was estimated to be
49% (95% CI 38–54%) at age 15, 39% (95% CI 30–46) at age 18, and 37% (95% CI 29–42) at
ages 20–28, with the remaining variance being due to non-shared environment. ORs for co-
existing neuropsychiatric and alcohol-related problems ranged from 2.3 to 13.2.
Conclusions. Clinically significant BDD symptoms are relatively common in adolescence and
young adulthood, particularly in females. The low occurrence of BDD symptoms in adoles-
cent boys may indicate sex differences in age of onset and/or etiological mechanisms. BDD
symptoms are moderately heritable in young people and associated with an increased risk
for co-existing neuropsychiatric and alcohol-related problems.
Introduction
Body dysmorphic disorder (BDD) is characterized by an intense preoccupation with perceived,
or slight, defects in physical appearance, which is typically, accompanied by compulsive beha-
viors. The insight that the perceived defects or flaws in appearance are within ‘normal’ limits,
and in most cases not visible to others, is usually poor but it varies along a continuum from
fair insight to delusional beliefs (American Psychiatric Association, 2013). BDD affects some
0.7–2.4% of the adult population, with the disorder being slightly more common in women
(Koran et al. 2008; Buhlmann et al. 2010; Veale et al. 2016). Very few studies exist on the
prevalence of BDD in young people. In one community sample (age 12–18 years, mean =
14.5) the prevalence of BDD symptoms in adolescence was 1.7%, with no sex differences
(Schneider et al. 2016). In another sample consisting of high school students (age 14–19
years, mean = 15.8), the estimated prevalence was 2.2%, with BDD symptoms being more com-
mon in girls with a female-to-male ratio of 1.64 (Mayville et al. 1999). Finally, in a non-clinical
sample of adolescents and young adults (age 15–21, mean 17.1) the estimated prevalence was
3.6%, with a higher prevalence in girls (Möllmann et al. 2017). However, due to the sample
consisting primarily of females, no firm conclusions could be drawn regarding possible sex dif-
ferences. These studies indicate that BDD symptoms are common already in this age group,
but more work is needed in order to elucidate possible sex differences that may occur in
young people.
Even though BDD is associated with marked impairment, suffering, and suicidality
(Phillips et al. 2005; Phillips & Menard, 2006), it has been historically understudied and
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research into the etiology of BDD is still in its infancy. Family
studies have found evidence of familial transmission of BDD
(Bienvenu et al. 2000; Phillips et al. 2005), and recent twin studies
have started to disentangle to what degree genetic and environ-
mental factors contribute to the liability of body dysmorphic
symptoms. In adults, the heritability of body dysmorphic con-
cerns has been estimated to 42–44%, with non-shared environ-
mental factors accounting for the remaining variance (Monzani
et al. 2011, 2014; López-Solà et al. 2014). As previous twin studies
have included only adult twins, the heritability of BDD symptoms
among young people remains unknown. BDD has a retrospect-
ively reported mean age of onset at 16 (Gunstad & Phillips,
2003; Phillips et al. 2005), moreover, it is known that genetic
influences of behavioral traits may change with age (Bergen
et al. 2007). Currently, the genetic architecture and risk factors
for BDD in adolescence and across the lifespan remain largely
unknown.
Despite scant research, findings from studies using conveni-
ence sampling suggest that the patterns of comorbidity in adoles-
cents are similar to those observed in adult samples (Phillips et al.
2006), but the association between BDD and developmentally
relevant conditions such as attention-deficit/hyperactivity dis-
order (ADHD) or autism spectrum disorder (ASD) has not
been studied. Furthermore, although comorbid substance abuse
and BDD has been associated with higher rates of lifetime suicide
attempts (Kelly et al. 2017), the risk for alcohol abuse in young
people with BDD remains largely unknown. It is of clinical
importance to establish to what extent BDD symptoms in
young people co-occur with other psychiatric symptoms.
Indeed, a better understanding of these patterns may have noso-
logical as well as clinical implications for prognosis and treatment.
In this study, we used data from a validated screening tool for
BDD in 15 377 twins from the Swedish Twin Registry to estimate
the prevalence of clinically significant BDD symptoms in adoles-
cents and young adults. We also report on the contribution of
genetic and environmental risk factors to the liability of body dys-
morphic concerns at crucial times of its development, and the risk
for co-existing psychopathology in cases with clinically significant
BDD symptoms.
Method
Study population
The study ‘Child and Adolescent Twin Study in Sweden’ (CATSS;
Anckarsäter et al. 2011) is a prospective longitudinal study of all
twins born in Sweden since July 1992. Parents of these twins were
interviewed when the twins were 9 or 12 years old (CATSS-9/12)
and further information was collected at ages 15 (CATSS-15), and
18 (CATSS-18). At the follow-ups, the twins were asked to com-
plete a battery of questionnaires, including a measure of body dys-
morphic concerns. In CATSS-15, body dysmorphic data were
available for 6968 twin individuals (response rate = 53% of all
Swedish twins in the age group), and in CATSS-18 the sample
included 3738 individuals with available body dysmorphic data
(response rate = 48%).
The ‘Young Adult Twins in Sweden Study’ (YATSS 20–28)
is a separate survey that ran from March 2013 to January 2014
and included all young adult twins born in Sweden from May
1985 to June 1992. There is no overlap between CATSS and
YATSS cohorts. The twins were contacted and asked to complete
a survey consisting of questions evaluating somatic illnesses and
psychiatric disorders, including a measure of body dysmorphic
concerns. Detailed information about the YATSS 20–28 cohort
can be found in Ivanov et al. (2017). Data on body dysmorphic
symptoms were available for 4671 individual twins (response
rate = 29%), the mean age of participants in the YATSS 20–28
cohort was 23.9 years (S.D. = 2.0, median = 24.0, range = 20–28).
Demographic characteristics in all samples are displayed in
Table 1.
Zygosity was determined by 49 single-nucleotide polymorph-
isms (SNPs; Hannelius et al. 2007). If DNA was unavailable, an
algorithm based on twin similarity that correctly classifies 95%
of twins compared with DNA testing was used (Magnusson
et al. 2013). The Regional Ethics Review Board in Stockholm
approved all data collection points and samples included in the
study (reference numbers 02–289, 03–672, 2009–739–31/5,
2010/1410–31/1, and 2012/2107–31/3).
Measures
Body dysmorphic disorder
The Dysmorphic Concern Questionnaire (DCQ; Oosthuizen et al.
1998) is a seven-item, self-report measure that assesses concern
with one’s own physical appearance and bodily function.
Responders rate their concern about their physical appearance
relative to others on a four-point scale ranging from 0 (none)
to 3 (much more than most people), yielding a total score between
0 and 21. The DCQ has good psychometric properties; it dis-
criminates BDD from clinical controls and appears to be a
useful screening instrument for BDD in non-clinical samples
(Oosthuizen et al. 1998; Jorgensen et al. 2001; Stangier et al.
2003; Mancuso et al. 2010). As concerns with physical appearance
are not limited to BDD, we slightly modified the DCQ instruc-
tions to state that the responder should not include concerns
related to ‘weight or being too fat’ when answering the questions.
This was done to better capture the BDD phenotype and to
exclude answers from participants whose primary concerns
were dissatisfaction with body size or appearance concerns due
to being overweight. In an attempt to identify participants
whose concerns were due to an objective disfigurement caused
by a medical condition or injury, the following question was
added to the DCQ: ‘Are your appearance concerns due to an
injury or medical condition that has disfigured you or signifi-
cantly changed your appearance? If yes, please specify’
Participants who answered yes and provided clear and recogniz-
able causes for disfigurement (e.g. amputations, cleft lip, vitiligo,
scoliosis) were excluded from the analysis.
Different cut-off points have been proposed for the DCQ, but
here we only report prevalence estimates for the highest proposed
cut-off ⩾17 in order to differentiate BDD symptoms from eating
disorder symptomatology (Stangier et al. 2003; Mancuso et al.
2010; Monzani et al. 2011). Furthermore, we validated the DCQ
using data from the current sample combined with cases fulfilling
DSM-5 diagnostic criteria for BDD ascertained from three clinical
samples (Monzani et al. 2013; Enander et al. 2014, 2016). The
area under the curve was 0.98 (95% CI = 0.97–0.99) when com-
paring patients diagnosed with BDD and non-BDD participants
from the twin samples. Using the cut-off ⩾17 correctly identified
96% of diagnosed patients with a sensitivity of 56% and a speci-
ficity of 99% (details of the psychometric evaluation of the DCQ
are available from the first author upon request). The DCQ dis-
played good internal consistency across all cohorts (Cronbach’s
α = 0.85–0.89), and a principal component analysis revealed a
2 Jesper Enander et al.
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single factor structure explaining 54–58% of the variance. Due to
positive skewness in total DCQ scores in all three cohorts
(CATSS-15 skewness = 1.51; CATSS-18 skewness = 1.61; YATSS
20–28 skewness = 1.61), a logarithmical transformation using
the natural logarithm was performed, resulting in reduced skew-
ness (CATSS-15 skewness = 0.02; CATSS-18 skewness = 0.09;
YATSS 20–28 skewness = 0.18).
Neuropsychiatric disorders
In CATSS-9/12, parents of twins were interviewed with the
Autism-Tics, ADHD, and other co-morbidities inventory
(A-TAC; Hansson et al. 2005) A-TAC is a validated telephone
interview with questions regarding lifetime symptoms of
ADHD, and ASD closely mapped after the corresponding
DSM-IV criteria. A cutoff ⩾6 was used for ADHD, and a cutoff
⩾4.5 for ASD. These cutoffs have been validated as broad screen-
ing cutoffs to identify cases, with a higher sensitivity than speci-
ficity and have a good interrater agreement (Larson et al. 2010;
2014).
Obsessive-compulsive and related disorders
In CATSS-9/12, parents of twins were interviewed using two
A-TAC items addressing obsessions and compulsions, mapped
after the DSM-IV criteria for obsessive-compulsive disorder
(OCD; Hansson et al. 2005). In YATSS 20–28, the presence of
probable OCD was assessed with the Obsessive-Compulsive
Inventory Revised (OCI-R) using a validated cut-off ⩾21 (Foa
et al. 2002). The OCI-R was updated to reflect DSM-5 criteria
for OCD, and thus the items that assess hoarding symptoms
were removed. Hoarding symptoms were assessed with the
Hoarding Rating Scale-Self Report (HRS-SR; Tolin et al. 2010).
The presence of clinically significant hoarding symptoms was
defined as scoring at least moderate severity on items measuring
clutter and difficulties discarding and on at least one of the items
measuring distress and impairment. This procedure has previ-
ously been described as criteria for clinically significant hoarding
and closely resembles the DSM-5 criteria (Frost & Hristova,
2011).
Eating disorders
The Eating Disorder Inventory-2 (EDI-2; Garner et al. 1983) is a
validated instrument that can discriminate between patients with
eating disorders, other psychiatric disorders, and non-affected
individuals (Nevonen & Broberg, 2001; Nevonen et al. 2009).
In CATSS, a validated cutoff ⩾21 on the EDI-2 symptom index
(the total sum score of the drive for thinness, bulimia, and body
dissatisfaction subscales) was used as the threshold to identify
cases with clinically significant eating disorder symptomatology.
Table 1. Demographic and clinical characteristics of the twins at age 15 (CATSS-15), age 18 (CATSS-18), and ages 20–28 (YATSS)
Cohort
CATSS-15 (N = 6968) CATSS-18 (N = 3738) YATSS (N = 4671)
Sex, n (%)
Male 3166 (45) 1617 (43) 1764 (38)
Female 3802 (55) 2121 (57) 2907 (62)
Zygosity, n (%)
Monozygotic male 758 (11) 378 (10) 773 (17)
Monozygotic female 966 (14) 585 (16) 1358 (29)
Dizygotic male 926 (13) 514 (14) 409 (9)
Dizygotic female 1059 (15) 556 (15) 721 (15)
Dizygotic other sex 2518 (36) 1315 (35) 1271 (27)
Unknown zygosity 741 (11) 390 (10) 139 (3)
Twins from complete pairs 5598 2652 3008
Twins from incomplete pairs 629 696 1524
DCQ score, mean (SD)
Total 3.5 (4.0) 3.7 (4.4) 3.3 (4.0
Male 1.9 (2.8) 2.4 (3.3) 2.3 (3.2)
Female 4.8 (4.4) 4.6 (4.8) 3.8 (4.3)
Prevalencea, % (95% CI)b
Total 1.0 (0.8–1.3) 2.0 (1.6–2.6) 1.1 (0.8–1.4)
Male 0.2 (0.1–0.4) 0.4 (0.2–0.8) 0.6 (0.4–1.1)
Female 1.8 (1.4–2.3) 3.3 (2.5–4.2) 1.3 (1.0–1.8)
Sex ratio (male: female) 8 : 100 9 : 100 29 : 100
aClinical Significant Body Dysmorphic Symptoms defined as ⩾17 on the Dysmorphic Concerns Questionnaire (DCQ).
bConfidence intervals adjusted for the clustering of twins within families.
CATSS, Child And Adolescent Twin Study in Sweden; YATSS, Young Adult Twin Study in Sweden; SD, Standard Deviation; CI, Confidence interval.
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In YATSS 20–28, EDI-2 data were not available, instead two
dichotomously scored items were used to capture self-reported
lifetime occurrence of an eating disorder: ‘Have you ever had
bulimia nervosa/anorexia nervosa?’
Alcohol abuse
In CATSS-18, the Alcohol Use Disorders Identification Test
(AUDIT) was used to capture hazardous or harmful alcohol
use, with a score of ⩾8 to identify cases (Saunders et al. 1993).
Statistical analysis
We estimated the prevalence of BDD in the different age samples,
both combined and separately by sex. The association between
BDD and psychiatric comorbidity was examined using logistic
regression models. Odds ratios were adjusted for zygosity and
age (when appropriate). Confidence intervals were calculated
using a cluster-robust sandwich estimator accounting for correla-
tions within twin pairs.
Twin methodology relies on the comparison of monozygotic
twins who are assumed to be genetically identical, and dizygotic
twins who, on average, share 50% of their segregating alleles.
Further, the equal-environment assumption states that monozy-
gotic and dizygotic twins are equally correlated in their exposure
to environmental events of etiological importance, and has shown
strong empirical support in the study of psychiatric disorders
(Kendler et al. 1993). If genes influence a trait, there will be a
more pronounced similarity within monozygotic twins, compared
with within dizygotic twins. Twin pair correlations allow for
estimation of the variation in a phenotype attributed to additive
genetic (A), shared environmental (C), and non-shared environ-
mental (E) factors (including measurement error).
Only twins with known zygosity were included in the model-
fitting analyses (CATSS-15: n = 6227; CATSS-18: n = 3348; YATSS
20–28: n = 4532). All pairs where at least one twin had available
data were included in analyses. We estimated intraclass correla-
tions (i.e. the correlation between twins in a pair) for the DCQ
total scores in monozygotic and dizygotic twins. To assess the
appropriateness of data for heritability analyses we performed
assumptions tests separately for each age sample. In a first step,
a fully saturated model was fitted to estimate the means and
covariance matrices that provided the best fit for our data. In
the YATSS 20–28 sample, we additionally adjusted means for
age. We then proceeded to equate the means and variances across
twin order, zygosity, and sex to test whether any of these restric-
tions produced a worse fit, using likelihood ratio tests. The
assumption testing showed that the data were appropriate for her-
itability analyses, with the exception that males had significantly
lower mean scores in all three age groups on the DCQ ( p <
0.05 in all samples). We, therefore, allowed the means for males
and females to be different in the model fitting analysis.
Maximum-likelihood model fitting was performed for each age
sample separately (Neale & Cardon, 2013). As the objective is
to quantify the nature and magnitude in genetic and environmen-
tal risk factors for dysmorphic concerns, we chose to present mea-
sures of accuracy of the estimates (A, C, and E) and avoid
hypothesis testing. This is in line with the recommendations
based on simulations, which show that in such situations param-
eter estimates from the full model are typically more accurate than
those from submodels even if the latter provides a better model fit
(Sullivan & Eaves, 2002). Basic statistical analysis and data prep-
aration were performed using SAS 9.3. Twin analyses were
performed using the OpenMx package (openmx.psyc.virgina.edu)
in R (cran.r-project.org).
Results
Prevalence
The prevalence of clinically significant BDD symptoms, and a
likely diagnosis of BDD (a total score ⩾17 on the DCQ) in the
twin samples was 1.0% (95% CI 0.8–1.3) in CATSS-15, 2.0%
(95% CI 1.6–2.6) in CATSS-18, and 1.1% (95% CI 0.8–1.4) in
YATSS 20–28. Across all cohorts, the prevalence was significantly
higher in females than in males (CATSS-15,χ2 = 43.48 [ p < 0.001];
CATSS-18, χ2 = 38.76 [ p < 0.001]; YATSS 20–28 χ2 = 4.94 [ p =
0.03]). The prevalence in males increased significantly with age
(χ2 = 6.17 [ p = 0.01]; Table 1).
Heritability
Table 2 provides intraclass correlations for MZ and DZ twins.
Across all three cohorts, the intraclass correlations were higher
for MZ than for DZ twins, indicating genetic influences on
body dysmorphic concerns, however, the MZ correlations were
<1.0, also indicating environmental effects on the phenotype.
In all three cohorts, the ACE-model provided an adequate fit
to the data compared with the saturated model (p:s = 0.26–
0.43). The heritability of dysmorphic concerns was estimated to
be 49% (95% CI 38–54%) at age 15, 39% (95% CI 30–46%) at
age 18, and 37% (95% CI 29–42%) in young adults ages 20–28.
Shared environmental factors were estimated to be 0% in all
cohorts, with the remaining variance being accounted for by non-
shared environmental factors, estimated to be 51% (95% CI 47–
56%) at age 15, 61% (95% CI 54–68%) at age 18, and 63%
(95% CI 58–69%) at ages 20–28 (Table 2).
Co-existence of psychiatric symptomatology
The number of males who screened positive for clinically signifi-
cant BDD symptoms was low, and as a result, the odds ratios
(ORs) could not be calculated for this group due to zero values.
Because of this, only results in females are presented. Overall,
the co-existence of any psychiatric symptomatology in cases
with clinically significant BDD symptoms was common in all
three age groups. Sixty-five percent (95% CI 54–76%) of BDD
cases in CATSS-15, 61% (95% CI 50–73%) in CATSS-18, and
45% (95% CI 31–59%) in YATSS 20–28 screened positive for at
least one comorbid disorder. The ORs for specific co-existing psy-
chiatric symptoms in females with clinically significant BDD
symptoms compared with individuals without clinically signifi-
cant BDD symptoms are shown in Table 3. In CATSS-15, females
with BDD were twice as likely as unaffected individuals to endorse
comorbid ADHD and showed a fivefold risk for ASD. The risk for
co-occurring obsessive-compulsive and related disorders (OCD or
hoarding disorder) showed a five to sevenfold increase at age 18,
and ages 20–28 years, but no increased risk was observed at age
15. Clinically significant eating disorder symptomatology (mea-
sured with EDI-2) in individuals with BDD was high at both
ages 15, and 18, with a 13- and 7-fold increased risk, respectively.
At age 20–28, women who screened positive for BDD were four
times more likely to endorse a lifetime occurrence of bulimia
nervosa, but no increased risk for the co-occurrence of anorexia
nervosa was observed. Furthermore, of those with BDD, 43%
4 Jesper Enander et al.
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reported problematic drinking, with a threefold increased risk for
alcohol abuse.
Discussion
To our knowledge, this is the first genetic epidemiological study of
body dysmorphic concerns in a large population-based sample
of adolescents and young adults (N = 15 377). The occurrence of
cases with clinically significant BDD symptoms and a likely diag-
nosis of BDD was estimated to be around 1–2%, with the preva-
lence being significantly higher in females across all cohorts. The
estimated heritability of body dysmorphic concerns was moderate
across the age groups, with the remaining variance explained by
non-shared environmental effects. The highest heritability was
observed in age 15 (49%), it then slightly diminished with age
and was estimated at 39% in 18-year olds, and at 37% in ages
20–28. Our findings also show that individuals with clinically sig-
nificant BDD symptoms had an increased risk for co-existing
neuropsychiatric, OCD spectrum and alcohol-related psychiatric
symptoms measured in childhood and adulthood.
Our nation-wide sample shows that clinically significant BDD
symptoms are relatively common in these age groups, and con-
firms the retrospective reports of age at onset described by adults
diagnosed with BDD (Gunstad & Phillips, 2003; Phillips et al.
2005). The occurrence is also in line with the suggested prevalence
of clinically significant BDD symptoms reported in community
samples of adolescents (Mayville et al. 1999; Schneider et al.
2016). In adults, the sex ratio of BDD is about equal (Veale
et al. 2016), but there has been uncertainty with regards to sex dif-
ferences in the occurrence of BDD symptoms in young people.
One study has indicated that there are no sex differences
(Schneider et al. 2016), whilst another two studies have indicated
that females are more likely to endorse symptoms of BDD
(Mayville et al. 1999; Möllmann et al. 2017). Our population-
based sample shows that BDD symptoms are significantly ele-
vated in females compared to males, but also suggest that the
occurrence of BDD symptoms in males increases with age. This
may indicate sex differences in age of onset, where females experi-
ence symptoms earlier in life. Sex differences in age of onset could
explain why the sex ratio differs in young people but is reported
to be about equal in adults. Furthermore, this is corroborated
by anecdotal evidence that boys with BDD less frequently present
themselves at the child and adolescent psychiatric clinics, and by
the low participation of boys in clinical trials of BDD (Mataix-
Cols et al. 2015). An additional explanation for the observed
sex differences is that these may be due to hormonal activation
that takes place during pubertal development. In other internaliz-
ing disorders (such as depression, anxiety) the sex ratio is equal
before puberty, but the symptoms become more prevalent in
girls after puberty (Hayward & Sanborn, 2002; Angold &
Costello, 2006). Specifically, more advanced Tanner stages of
pubertal development in girls predict the sex differences in the
occurrence of internalizing disorders better than age (Hayward
& Sanborn, 2002), suggesting that sex hormones play a part in
the pathophysiology of these disorders. Furthermore, preliminary
evidence suggests that estradiol levels moderate the magnitude of
genetic effects for disordered eating during puberty (Klump et al.
2010). Sex-specific hormonal activation such as estrogen and tes-
tosterone during puberty may possibly account for at least part of
the sex differences in clinically significant BDD symptoms
amongst youth observed in this and other studies. Nonetheless,
it should be noted that the association between hormones andTa
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BDD has not yet been studied and we do not have access to blood/
saliva samples or Tanner stages in our data to directly address this
hypothesis; this warrants further investigation.
Two studies have previously estimated the heritability of dys-
morphic concerns in adults using the same instrument as admi-
nistered in this study (DCQ). One study consisting of 3544
adult female twins (mean age of 57) recruited from the
TwinsUK registry estimated the heritability at 44% (95% CI 37–
50%). In the other twin study (N = 2495), consisting of twins of
both sexes with a mean age of 35, recruited from the Australian
Twin Registry, the heritability was 42% (95% 30–52%). Our
heritability estimates were largest at age 15, and then tended to
non-significantly decrease with age but, in general, the heritability
estimates in the current study are in line with those previously
reported in adults (Monzani et al. 2011; López-Solà et al. 2014).
Further longitudinal studies of the development of BDD symp-
toms across the lifespan are needed in order to evaluate whether
the relative genetic and environmental factors on BDD symptoms
vary over time, as suggested in other disorders such as OCD
(Krebs et al. 2014; Zilhão et al. 2015). The results confirm that
BDD has a genetic basis and should encourage researchers to ini-
tiate collaborations to gather sufficient DNA samples for study
of associated genetic markers; given the suspected shared etiology
with other disorders in the OCD spectrum (Monzani et al. 2014),
recent advances in OCD genetics (Mattheisen et al. 2015; Noh
et al. 2017) may help accelerate the discovery of BDD-related
genes as well.
Across the cohorts, the shared environment was negligible.
Instead, unique environmental factors contributed to the risk of
developing body dysmorphic concerns. No environmental risk fac-
tors for BDD have yet been identified, although, some research
suggests that young people with BDD report more appearance-
related teasing (Buhlmann et al. 2007). Since non-shared environ-
ment constitutes a substantial proportion of the variance in the
phenotypic expression, future population-based research is needed
to identify the nature of these risk factors. This has recently been
done in OCD, where for example, smoking during pregnancy or a
range of obstetric complications were associated with a higher risk
of developing OCD while controlling for familial confounders
(Brander et al. 2016).
To our knowledge, this is the first study to report on the
co-occurrence of neuropsychiatric symptoms in adolescents
with BDD symptoms. At age 15, twins with BDD symptoms
showed an increased risk of ADHD and ASD symptoms com-
pared with non-BDD subjects. In BDD, impaired executive func-
tioning has been reported (Dunai et al. 2009), and the association
between ADHD/ASD and BDD in adolescents warrants further
investigation in clinically ascertained samples; whether these
neuropsychiatric comorbidities interfere with the treatment of
BDD is a particularly relevant question. In DSM-5, BDD is clas-
sified in the obsessive-compulsive and related disorders chapter
and has shown to share a genetic risk factor, particularly with
OCD and HD (Monzani et al. 2014). The observed risk for the
co-occurrence of these symptom clusters in twins with BDD
symptoms in the general population gives further support for a
link between these disorders. The risks for clinical significant eat-
ing disorder symptoms and lifetime bulimia nervosa was elevated
in twins with BDD symptoms, and the pattern of co-occurrence
in this representative sample of young people is similar to that
observed in clinical samples of adults diagnosed with BDD
(Phillips, 1991; Gunstad & Phillips, 2003). A feature common
in both BDD and eating disorders is the concern about one’s
appearance and a negative body image that may constitute an
underlying liability, and potentially shared genetic factors between
the disorders, which warrant further investigation.
Forty-three percent of females aged 18 with clinical significant
BDD symptoms screened positive for problematic drinking, with
a three-fold increase in risk when compared with non-BDD sub-
jects. In adults diagnosed with BDD, the lifetime occurrence of
an alcohol-use disorder has been estimated to 29–43%, with a
Table 3. Risk for co-existing psychopathology in females with clinically significant body dysmorphic symptomsa in CATSS-15, CATSS-18, YATSS 20–28 and when
compared with females without symptoms
Cohort
CATSS-15 CATSS-18 YATSS 20–28
nb OR (95% CI) nb OR (95% CI) nb OR (95% CI)
ADHD 7/54 2.3 (1.1–5.2) 4/56 1.7 (0.6–4.7) n/a n/a
ASD 3/54 5.2 (1.5–17.6) 2/56 3.5 (0.8–15.5) n/a n/a
OCD 1/54 2.32 (0.3–17.6) 0/56 – 13/39 7.2 (3.6–14.2)
Hoarding disorder 3/67 3.0 (0.9–9.6) 4/75 5.4 (1.8–15.9) 2/38 6.8 (1.5–30.8)
Eating disorder 43/63 13.2 (7.7–22.5) 34/65 6.8 (4.0–11.5) n/a n/a
Anorexia nervosa n/a n/a n/a n/a 4/39 2.3 (0.8–6.7)
Bulimia nervosa n/a n/a n/a n/a 4/39 3.9 (1.4–11.4)
Alcohol abuse n/a n/a 24/56 3.4 (2.0–5.8) n/a n/a
Bold indicates p < 0.05.
–, Values for OR and 95% CI could not be calculated due to zero values.
n/a, not available.
aClinically Significant Body Dysmorphic Symptoms defined as ⩾17 on the Dysmorphic Concerns Questionnaire (DCQ).
bNumber of twins with clinically significant BDD symptoms whom also scored above cut-off on measures of psychiatric psychopathology. The denominator varies as not all cases had
complete data on measurements of psychopathology.
CATSS, Child And Adolescent Twin Study in Sweden; YATSS 20–28, Young Adult Twin Study in Sweden; OR, Odds ratio; CI, Confidence Interval; ADHD, Attention deficit/hyperactivity disorder;
ASD, Autism spectrum disorder; OCD, Obsessive-compulsive disorder.
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majority of patients reporting that BDD contributed to their
alcohol use, and that they drank in order to alleviate negative
affect and to cope with distress due to body image concerns
(Grant et al. 2005; Kelly et al. 2017). Furthermore, drinking as
a way to cope with negative effect in BDD has been shown to
be associated with lifetime rates of attempted suicide (Kelly
et al. 2017). This suggests that young patients with BDD and
co-occurring alcohol misuse should be more carefully monitored
for suicidal ideation. Moreover, clinicians should routinely screen
adolescent BDD patients for alcohol use disorder as the risk for
problematic drinking is elevated among adolescents with clinic-
ally significant BDD symptoms.
Strengths of this study include a nationwide population-based
sample of 15 377 adolescents and young adults, and the use of a
validated instrument for assessing body dysmorphic concerns and
a probable diagnosis of BDD. However, this study also has several
limitations. We validated the DCQ in the twin samples using data
from patients diagnosed with BDD, and excluded cases with real
disfigurements; however, we cannot be certain that all the twin
cases that screened positive for clinically significant BDD symp-
toms on the DCQ would fulfill a diagnosis of BDD if assessed
by a clinician. Response rates in the different age groups varied
from 29 to 53%. Overall, non-responders in the CATSS cohort
at ages 9 and 12 are more likely than responders to be socially dis-
advantaged and present with different types of health problems
but the differences are so small that, with the possible exception
of learning disorders, the results are likely generalizable to the
total population (Anckarsäter et al. 2011). However, a similar
study would be required at ages 15, 18 and 20–28 to draw any
firm conclusions about the representativeness of our cohorts.
Although modeled after DSM-IV criteria, comorbid OCD was
not determined using a validated measure and was only based
on a parental report at ages 9/12 for the CATSS-twins
(Hansson et al. 2005). This, taken together with evidence suggest-
ing that females are more likely to have a late onset of OCD
(Taylor, 2011) may have led to an underestimation of the occur-
rence of OCD in the younger age groups, and thus the risk for
co-occurring OCD in these age groups should be interpreted
with caution. Furthermore, due to the low prevalence of clinically
significant BDD symptoms in males, we could only assess the risk
of co-existing psychopathology in females. The comorbidity esti-
mates should also be interpreted with caution due to the small
number of twins that screened positive for BDD and other mental
disorders. It should also be noted that due to positive skewness
in total DCQ scores, a logarithmical transformation was per-
formed, which should be taken into account when interpreting
the results. Lastly, the prevalence estimates and patterns of psychi-
atric co-occurrence may have been affected by the lower response
rate in the older age groups, as it is plausible that the most
extreme cases may be more likely to be non-responders.
Conclusion
In conclusion, we report the largest twin study of body dys-
morphic concerns to date, including estimates of the occurrence
of clinically significant BDD symptoms and the risk for co-exist-
ing psychiatric symptoms in a representative sample of adoles-
cents and young adults. The prevalence clinically significant
BDD symptoms and a likely diagnosis of BDD was 1–2%, with
the occurrence of BDD in males being rare in ages 15 and 18,
but increased significantly in ages 20–28. This may indicate sex
differences in age of onset, where males may develop clinically
significant BDD symptoms later in life. Overall, the heritability
of body dysmorphic concerns in young people are moderate
and broadly comparable to that of adults. Our data also show
that the co-existence of psychopathology is common in young
people with clinically significant BDD symptoms. Moreover, the
risk for problematic drinking is elevated; indicating that patients
should routinely be screened for alcohol use disorder as comorbid
substance abuse and BDD has been associated with higher rates of
lifetime suicide attempts.
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